Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
RETRACTION : DPM2 Serve as Novel Oncogene and Prognostic Marker Transactivated by ESR1 in Breast Cancer
RETRACTION : DPM2 Serve as Novel Oncogene and Prognostic Marker Transactivated by ESR1 in Breast Cancer
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Environmental Toxicology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
RETRACTION: Integrated RNA Expression and Alternative Polyadenylation Analysis Identified CPSF1 ‐ CCDC137 Oncogenic Axis in Lung Adenocarcinoma
Published: (2025)
RETRACTION : Research on the Toxicological Prognostic Significance of Age‐Related Genes in Endometrial Cancer Unveiling Key Factors in Patient Prognosis
Published: (2025)
RETRACTION : Identification of Potential Therapeutic Targets for Breast Cancer Using Mendelian Randomization Analysis and Drug Target Prediction
Published: (2025)
RETRACTION : SIK2 ‐Positive Tumor Epithelial Cells in Breast Cancer Maybe Potential Anti‐Cancer Messengers: A Systematic Analysis from a Single‐Cell Perspective
Published: (2025)
RETRACTION : Circular Forms of Dedicator of Cytokinesis 1 Promotes Breast Cancer Progression by Derepressing Never in Mitosis Related Kinase 2 via Sponging miR ‐128‐3p
Published: (2024)
